Dermira Closes $42M

Redwood City, Calif.-based Dermira has raised $42 million in Series A financing to back the acquisition, development and commercialization of novel therapeutics in dermatology. Investors include Bay City Capital, New Enterprise Associates and Canaan Partners. In conjunction with the financing, Dermira also said that it has acquired Valocor Therapeutics, which has a pipeline of development stage dermatology programs for the treatment of acne, inflammatory skin diseases, and other conditions.

North AmericaUSBriefs